Compare BioNano Genomics Inc (BNGO) vs Lennar Corporation (LEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Lennar Corporation — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while Lennar Corporation trades at $87.46 (market cap $21.05B). The key difference: Lennar Corporation is far larger — about 1541× BioNano Genomics Inc's market cap, and Lennar Corporation pays a 2.28% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | LEN | |
|---|---|---|
Market Cap | $13.66M | $21.05B |
Sector | Health | Consumer Cyclical |
52-Week High | $4.92 | $142.40 |
52-Week Low | $1.06 | $81.84 |
Enterprise Value | $16.26M | $24.93B |
Dividend Yield | — | 2.28% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Lennar Corporation
Lennar is the second-largest public homebuilder in the United States. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily construction and has invested in numerous housing-related technology startups.
Read more on LEN →
